ANGELA JONES: Open Payments
NPI 1194023762 · CLINTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,310 in 92 payments from 15 companies in 2025. Trend: 2023 $1,312 · 2024 $1,498 · 2025 $2,310
Food & beverage: $2,310
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $482 |
| ABBVIE INC. | 22 | $319 |
| Axsome Therapeutics, Inc. | 6 | $313 |
| Collegium Pharmaceutical, Inc. | 6 | $179 |
| Boston Scientific Corporation | 2 | $157 |
| Lilly USA, LLC | 2 | $152 |
| E.R. Squibb & Sons, L.L.C. | 4 | $146 |
| Corium, LLC | 13 | $131 |
| Alkermes, Inc. | 6 | $116 |
| Lundbeck LLC | 5 | $101 |
Products named: CAPLYTA, Auvelity, VRAYLAR, Jornay PM, COBENFY, ZEPBOUND, Azstarys, REXULTI.
Industry payments across LA — which companies pay providers there.
